On September 7, 2022 INmune Bio (NASDAQ: INMB), a clinical- stage immunology company focused on developing treatments that harness the patient’s immune system to fight disease, reporte that RJ Tesi, M.D., Chief Executive Officer will present a corporate overview at the H.C. Wainwright 24th Annual Global Investment Conference being held on September 12 – 14, 2022, and the Baird Global Healthcare Conference being held on September 13 – 14, 2022 (Press release, INmune Bio, SEP 7, 2022, View Source [SID1234619227]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H. C. Wainwright Global Healthcare Conference

Baird Global Healthcare Conference

Management will be available for one-on-one meetings. To request a meeting and to register for the conference, click here: View Source